Brandon Dionne
@bwdionne.bsky.social
Associate Clinical Professor at Northeastern University School of Pharmacy and Pharmaceutical Sciences
Infectious Diseases Clinical Pharmacist at Brigham and Women's Hospital.
He/him.
Infectious Diseases Clinical Pharmacist at Brigham and Women's Hospital.
He/him.
Ceftriaxone is not a strong inducer, though. This is the concern with bacteria with inducible ampC; the mechanism that allows inducibility can result in a resistant subpopulation with mutations that cause "stably derepressed" AmpC production that is hidden by the larger susceptible population.
November 24, 2025 at 8:42 PM
Ceftriaxone is not a strong inducer, though. This is the concern with bacteria with inducible ampC; the mechanism that allows inducibility can result in a resistant subpopulation with mutations that cause "stably derepressed" AmpC production that is hidden by the larger susceptible population.
Yes, they mention that in the recently published scientific statement from the AHA that you referenced.
September 16, 2025 at 8:20 PM
Yes, they mention that in the recently published scientific statement from the AHA that you referenced.
This is true, but do you know what the more common cause is?
September 15, 2025 at 8:45 PM
This is true, but do you know what the more common cause is?